Tango Therapeutics, Inc.
TNGX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$130,302 | -$101,744 | -$108,176 | -$58,235 |
| Dep. & Amort. | $2,499 | $2,415 | $1,608 | $897 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $28,897 | $19,079 | $14,230 | $7,833 |
| Change in WC | -$31,746 | -$37,966 | -$18,493 | -$11,345 |
| Other Non-Cash | -$849 | $234 | $1,751 | $1,323 |
| Operating Cash Flow | -$131,501 | -$117,982 | -$109,080 | -$59,527 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$754 | -$1,526 | -$7,692 | -$1,837 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$240,888 | -$310,574 | -$208,504 | -$372,361 |
| Inv. Sales/Matur. | $327,768 | $353,526 | $242,595 | $190,764 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $86,126 | $41,426 | $26,399 | -$183,434 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $342,113 |
| Stock Issued | $41,723 | $80,017 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $5,941 | $2,389 | $1,615 | $15,212 |
| Financing Cash Flow | $47,664 | $82,406 | $1,615 | $357,325 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $2,289 | $5,850 | -$81,066 | $114,364 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $69,808 | $63,958 | $145,024 | $30,660 |
| End Cash | $72,097 | $69,808 | $63,958 | $145,024 |
| Free Cash Flow | -$132,255 | -$119,508 | -$116,772 | -$61,364 |